安慰剂组

• Results showed that when patients were lying down , pycnogenol ? treatment improved capillary blood flow by 34 percent , compared to 4 . 7 percent in the placebo group
  实验结果表明，当病人平躺时，碧萝芷?组病人的的血流速度提高了37 % ，而安慰剂组仅提高了4 . 7 % 。
• In the three - year analysis , there was no statistically significant difference in cancer incidence between participants taking placebos and those taking just calcium supplements
  在后三年内，统计数据表明，安慰剂组与单纯摄入钙组相比，两者的癌症发生率没有显著差别。
• The mean time required for the complete absorption was 5 . 2 days for the haematomas treated with hirudoid , 8 . 1 days for those treated with placebo and 10 days for the untreated ones
  血肿完全吸收所需要的平均时间，喜疗妥组为5 . 2天，安慰剂组为8 . 1天，而未治疗组为10天。
• Treatment was effectie with serum folate concentrations increasing by 576 % and plasma homocysteine falling by 26 % for the folic acid group compared with placebo
  这句话没翻译。试译：叶酸治疗组与安慰剂组比较，血清叶酸浓度增加576且血浆同型半胱氨酸水平下降26视为治疗有效。
• When patient ' s blood flow was measured in a standing position , pycnogenol ? treatment improved capillary blood flow by 68 percent , compared to 8 percent in the placebo group
  当在病人站立状态进行血流速度测量时，碧萝芷?组病人毛细血管的血流速度提高了68 % ，而安慰剂组仅提高了8 % 。
• Oerall , after four weeks ' treatment , for the primary endpoint , study participants were ealuated for reductions in total nasal symptom scores for ffns compared with placebo
  经4周的治疗后，对主要时间点，全部参与研究者评价其全鼻症状评分，并且氟替卡松安特酰胺鼻腔喷雾组评分与安慰剂组相比较减少。
• The rate of falling during the fie - month long study was the same , statistically , among those on placebo and those on 200 , 400 or 600 iu of itamin d daily , ranging from 44 to 60 percent , the researchers found
  经过统计分析，在为期5个月的研究中，每日摄入200 、 400或600单位维生素d组与安慰剂组的摔倒率相同。
• The rate of falling during the five - month long study was the same , statistically , among those on placebo and those on 200 , 400 or 600 iu of vitamin d daily , ranging from 44 to 60 percent , the researchers found
  经过统计分析，在为期5个月的研究中，每日摄入200 、 400或600单位维生素d组与安慰剂组的摔倒率相同。
• The only aderse eent that occurred in more than 2 percent of patients in any treatment group was headache in 3 ( 2 . 0 percent ) patients receiing nasonex , 4 ( 2 . 7 percent ) receiing placebo , and 0 receiing astelin
  每组仅有2 %的患者有不良反应，内舒拿组有3名患者出现头痛（ 2 % ） ，安慰剂组有4名（ 2 . 7 ） ，氮卓斯汀喷雾剂组无不良反应。